 POTOMAC, Md.--BUSINESS WIRE-- AD--India Globalization Capital, Inc. IGC or the Company NYSE American: IGC today announced its financial results for the quarter ended September 30, 2020, which is the second quarter of its 2021 fiscal year, and the start of Phase 1 cannabinoid-based clinical trial for Alzheimers Patients. Revenue in the quarter ended September 30, 2020 and September 30, 2019, were 125 thousand and 1,821 thousand, respectively. The decrease in revenue is primarily due to r 